{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T04:00:06Z","timestamp":1770436806574,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ejim.2011.08.030","type":"journal-article","created":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T01:12:45Z","timestamp":1317431565000},"page":"9-14","source":"Crossref","is-referenced-by-count":35,"title":["Non-dietary therapeutic clinical trials in coeliac disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Laura","family":"Crespo P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Castillejo de Villasante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Cano Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2011.08.030_bb0005","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(09)60254-3","article-title":"Coeliac disease","volume":"373","author":"Di Sabatino","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2011.08.030_bb0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJMra010852","article-title":"Celiac sprue","volume":"346","author":"Farrel","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.08.030_bb0015","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMra071600","article-title":"Celiac disease","volume":"357","author":"Green","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.08.030_bb0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bpg.2005.01.006","article-title":"Coeliac disease","volume":"19","author":"Mulder","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2011.08.030_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(03)14027-5","article-title":"Coeliac disease","volume":"362","author":"Green","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2011.08.030_bb0030","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1053\/j.gastro.2009.09.008","article-title":"Celiac disease: from pathogenesis to novel therapies","volume":"137","author":"Schuppan","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.08.030_bb0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1157\/13080614","article-title":"Screening of celiac disease in high risk groups","volume":"28","author":"Fern\u00e1ndez-Ba\u00f1ares","year":"2005","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2011.08.030_bb0040","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.163.3.286","article-title":"Prevalence of celiac disease in at risk and not-at-risk groups in the United States: a large multicenter study","volume":"63","author":"Fasano","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2011.08.030_bb0045","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa021687","article-title":"Prevalence of celiac disease among children in Finland","volume":"348","author":"Maki","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.08.030_bb0050","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/003655200750023967","article-title":"Prevalence of coeliac disease in the general population of Northern Spain. Strategies of serologic screening","volume":"35","author":"Riestra","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.08.030_bb0055","doi-asserted-by":"crossref","first-page":"34109","DOI":"10.1074\/jbc.M204521200","article-title":"Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the influence on the transamidation versus deamidation process","volume":"277","author":"Fleckenstein","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejim.2011.08.030_bb0060","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm0698-713","article-title":"Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease","volume":"4","author":"Molberg","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.ejim.2011.08.030_bb0065","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1126\/science.1074129","article-title":"Structural basis for gluten intolerance in celiac disease","volume":"297","author":"Shan","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejim.2011.08.030_bb0070","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.4049\/jimmunol.161.4.1585","article-title":"Selective deamination by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity","volume":"161","author":"Van de Wal","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2011.08.030_bb0075","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0016-5085(03)01049-7","article-title":"Alterations of the intestinal transport and processing of gliadin peptides in celiac disease","volume":"125","author":"Matysiak-Budnik","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.08.030_bb0080","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1203\/00006450-199804000-00001","article-title":"Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue","volume":"43","author":"Schulzke","year":"1998","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ejim.2011.08.030_bb0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(03)13803-2","article-title":"Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease","volume":"362","author":"Mauri","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2011.08.030_bb0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature09849","article-title":"Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens","volume":"471","author":"DePaolo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2011.08.030_bb0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/08916930802350789","article-title":"Th17 (and Th1) signatures of intestinal biopsies of CD patients in response to gliadin","volume":"42","author":"Castellanos-Rubio","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejim.2011.08.030_bb0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1067\/mge.2003.54","article-title":"Duodenal histology in patients with celiac disease after treatment with a gluten-free diet","volume":"57","author":"Lee","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.ejim.2011.08.030_bb0105","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1365-2036.2006.02908.x","article-title":"Oats in the treatment of childhood celiac disease: a 2 year controlled trial and a long term follow up study","volume":"23","author":"Holm","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2011.08.030_bb0110","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1053\/j.gastro.2005.02.024","article-title":"Dietary guidelines and implementation for celiac disease","volume":"128","author":"Kupper","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.08.030_bb0115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcn\/85.1.160","article-title":"A prospective, double blind, placebo controlled trial to establish a safe gluten threshold for patients with celiac disease","volume":"85","author":"Catassi","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejim.2011.08.030_bb0120","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1365-2036.2009.03992.x","article-title":"Complete recovery of intestinal mucosa occurs very rarely in adult celiac patients despite adherence to gluten-free diet","volume":"29","author":"Lanzini","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2011.08.030_bb0125","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1365-2036.2008.03669.x","article-title":"Systematic review: tolerable amount of gluten for people with coeliac disease","volume":"27","author":"Akobeng","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2011.08.030_bb0130","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/01.meg.0000236884.21343.e4","article-title":"Consumption of gluten-free products: should the threshold value for trace amounts of gluten be 20, 100 or 200 ppm?","volume":"18","author":"Gibert","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2011.08.030_bb0135","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2036.2007.03413.x","article-title":"The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study","volume":"26","author":"Paterson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2011.08.030_bb0140","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1053\/gast.1997.v112.pm9041245","article-title":"The enterotoxic effect on zonula occludens toxin on rabbit small intestine involves the paracellular pathway","volume":"112","author":"Fasano","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.08.030_bb0145","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/IAI.71.4.1897-1902.2003","article-title":"Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responses","volume":"71","author":"Marinaro","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.ejim.2011.08.030_bb0150","first-page":"M2048","article-title":"Effect of larazotide acetate on the prevention of signs and symptoms of coeliac disease in patients undergoing a gluten challenge: a randomised placebo-controlled study","volume":"136","author":"Kelly","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.08.030_bb0155","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1542-3565(05)00366-6","article-title":"Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue","volume":"3","author":"Pyle","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2011.08.030_bb0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clim.2009.11.001","article-title":"The effects of ALV003 pre-digestion of gluten on immune and symptoms in celiac disease in vivo","volume":"134","author":"Tye-Din","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ejim.2011.08.030_bb0165","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/S0016-5085(10)60247-8","article-title":"Can prolyl-endoprotease enzyme treatment mitigate the toxic effect of gluten in coeliac patients?","volume":"138","author":"Tack","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.08.030_bb0170","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1517\/14656566.2011.592140","article-title":"Pharmacological and management strategies for coeliac disease","volume":"12","author":"Donnelly","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ejim.2011.08.030_bb0175","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.4049\/jimmunol.0900233","article-title":"Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells","volume":"182","author":"de Kauwe","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2011.08.030_bb0180","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1016\/S0016-5085(11)61794-0","article-title":"A phase i study to determine safety, tolerability and bioactivity of Nexvax2\u00ae in HLA DQ2+ volunteers with celiac disease following a long-term, strict gluten-free diet","volume":"140","author":"Brown","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.08.030_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04139.x","article-title":"The \u2018hygiene hypothesis\u2019 for autoimmune and allergic diseases: an update","volume":"160","author":"Okada","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2011.08.030_bb0190","doi-asserted-by":"crossref","first-page":"e17366","DOI":"10.1371\/journal.pone.0017366","article-title":"Effect of hookworm infection on wheat challenge in celiac disease\u2013a randomised double-blinded placebo controlled trial","volume":"6","author":"Daveson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2011.08.030_bb0195","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1517\/13543780903369333","article-title":"Investigational therapies for celiac disease","volume":"18","author":"Rodrigo","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ejim.2011.08.030_bb0200","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-2796.2011.02376.x","article-title":"Novel therapies for Coeliac Disease","volume":"296","author":"Sollid","year":"2011","journal-title":"J Intern Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511002172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511002172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T05:45:03Z","timestamp":1686375903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620511002172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0953620511002172"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2011.08.030","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}